JP2022514116A5 - - Google Patents
Info
- Publication number
- JP2022514116A5 JP2022514116A5 JP2021546487A JP2021546487A JP2022514116A5 JP 2022514116 A5 JP2022514116 A5 JP 2022514116A5 JP 2021546487 A JP2021546487 A JP 2021546487A JP 2021546487 A JP2021546487 A JP 2021546487A JP 2022514116 A5 JP2022514116 A5 JP 2022514116A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- sequence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022173369A JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18201634 | 2018-10-19 | ||
| EP18201634.5 | 2018-10-19 | ||
| PCT/GB2019/052980 WO2020079448A1 (en) | 2018-10-19 | 2019-10-18 | Novel cancer antigens and methods |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022173369A Division JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Division JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514116A JP2022514116A (ja) | 2022-02-09 |
| JP2022514116A5 true JP2022514116A5 (https=) | 2022-11-10 |
| JP7712207B2 JP7712207B2 (ja) | 2025-07-23 |
Family
ID=64183836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546487A Active JP7712207B2 (ja) | 2018-10-19 | 2019-10-18 | 新規な癌抗原及び方法 |
| JP2022173369A Active JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Pending JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022173369A Active JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Pending JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12263216B2 (https=) |
| EP (1) | EP3866827A1 (https=) |
| JP (3) | JP7712207B2 (https=) |
| KR (1) | KR20210080372A (https=) |
| CN (2) | CN112867501B (https=) |
| AU (1) | AU2019360427A1 (https=) |
| BR (1) | BR112021006941A2 (https=) |
| CA (1) | CA3112427A1 (https=) |
| EA (1) | EA202191081A1 (https=) |
| IL (1) | IL282308A (https=) |
| MX (1) | MX2021004453A (https=) |
| WO (1) | WO2020079448A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| MX2021015765A (es) * | 2019-06-28 | 2022-01-27 | The Francis Crick Institute Ltd | Nuevos antigenos y metodos contra el cancer. |
| CA3179694A1 (en) * | 2020-04-17 | 2021-10-21 | The Francis Crick Institute Limited | Fusion proteins of ctl antigens for treating melanoma |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0871747A1 (en) | 1996-01-02 | 1998-10-21 | Chiron Viagene, Inc. | Immunostimulation mediated by gene-modified dendritic cells |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| US7504490B1 (en) | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
| WO2001064835A2 (en) | 2000-02-28 | 2001-09-07 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AU2001249922A1 (en) | 2000-04-06 | 2001-10-23 | Pharmacia And Upjohn Company | G protein-coupled receptors |
| US20020082206A1 (en) | 2000-05-30 | 2002-06-27 | Leach Martin D. | Novel polynucleotides from atherogenic cells and polypeptides encoded thereby |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| JP2003304877A (ja) | 2002-04-15 | 2003-10-28 | Keio Gijuku | ヒト色素細胞特異分子 |
| AU2003298606A1 (en) | 2002-10-25 | 2004-05-13 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| WO2006105642A1 (en) | 2005-04-05 | 2006-10-12 | British Columbia Cancer Agency | Biomarkers for the detection of lung cancer and uses thereof |
| AT502292B1 (de) | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US20070072175A1 (en) | 2005-05-13 | 2007-03-29 | Biogen Idec Ma Inc. | Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof |
| EP1963534A2 (en) | 2005-12-19 | 2008-09-03 | Genizon Biosciences Inc. | Genemap of the human gene associated with crohn's disease |
| US8921050B2 (en) * | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US20090297530A1 (en) | 2006-05-22 | 2009-12-03 | Feng Wang-Johanning | Herv-k antigens, antibodies, and methods |
| EP2052088A2 (en) | 2006-08-02 | 2009-04-29 | Genizon Biosciences | Genemap of the human genes associated with psoriasis |
| WO2008118258A2 (en) | 2007-02-06 | 2008-10-02 | Genizon Biosciences Inc. | Genemap of the human genes associated with adhd |
| US8541553B2 (en) | 2007-05-24 | 2013-09-24 | Baxter Healthcare Sa | Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| WO2009026116A2 (en) | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| WO2009039244A2 (en) | 2007-09-18 | 2009-03-26 | Genizon Biosciences Inc. | Genemap of the human genes associated with crohn's disease |
| US8323659B2 (en) | 2008-09-18 | 2012-12-04 | Keio University | Method for diagnosing and/or treating tumor |
| WO2013040142A2 (en) | 2011-09-16 | 2013-03-21 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| NZ622148A (en) | 2011-08-30 | 2016-06-24 | Nat Defense Medical Ct | Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers |
| FR2984362B1 (fr) | 2011-12-20 | 2017-11-24 | Biomerieux Sa | Procede pour le diagnostic ou le pronostic in vitro du cancer du poumon |
| WO2014004385A2 (en) | 2012-06-25 | 2014-01-03 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
| ES2807791T3 (es) | 2014-12-08 | 2021-02-24 | Univ Michigan Regents | ARN no codificantes y usos de los mismos |
| GB201521894D0 (en) | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| CR20180551A (es) | 2016-04-21 | 2019-02-12 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cáncer |
| US20190351040A1 (en) | 2017-02-01 | 2019-11-21 | Modernatx, Inc. | Rna cancer vaccines |
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| EP3990007A2 (en) | 2019-06-28 | 2022-05-04 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| MX2021015765A (es) | 2019-06-28 | 2022-01-27 | The Francis Crick Institute Ltd | Nuevos antigenos y metodos contra el cancer. |
| EP3994156A1 (en) | 2019-07-05 | 2022-05-11 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| AU2020309202A1 (en) | 2019-07-05 | 2021-12-09 | Enara Bio Limited | Novel cancer antigens and methods |
-
2019
- 2019-10-18 BR BR112021006941-0A patent/BR112021006941A2/pt not_active IP Right Cessation
- 2019-10-18 CN CN201980068630.3A patent/CN112867501B/zh active Active
- 2019-10-18 JP JP2021546487A patent/JP7712207B2/ja active Active
- 2019-10-18 WO PCT/GB2019/052980 patent/WO2020079448A1/en not_active Ceased
- 2019-10-18 KR KR1020217010920A patent/KR20210080372A/ko not_active Ceased
- 2019-10-18 CN CN202411985215.3A patent/CN119978090A/zh active Pending
- 2019-10-18 EP EP19790765.2A patent/EP3866827A1/en active Pending
- 2019-10-18 AU AU2019360427A patent/AU2019360427A1/en not_active Abandoned
- 2019-10-18 EA EA202191081A patent/EA202191081A1/ru unknown
- 2019-10-18 CA CA3112427A patent/CA3112427A1/en active Pending
- 2019-10-18 MX MX2021004453A patent/MX2021004453A/es unknown
-
2021
- 2021-04-13 IL IL282308A patent/IL282308A/en unknown
- 2021-04-16 US US17/232,597 patent/US12263216B2/en active Active
-
2022
- 2022-10-28 JP JP2022173369A patent/JP7762132B2/ja active Active
-
2024
- 2024-12-05 JP JP2024212437A patent/JP2025041678A/ja active Pending
-
2025
- 2025-02-25 US US19/062,913 patent/US20250360206A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Cancer vaccines as promising immuno-therapeutics: platforms and current progress | |
| Senovilla et al. | Trial watch: DNA vaccines for cancer therapy | |
| CN109152830B (zh) | 用于免疫疗法的核/壳结构平台 | |
| ES2741147T3 (es) | Composición de vacuna | |
| CN103415620B (zh) | 诱导针对EGFRvIII的免疫应答的方法和组合物 | |
| JP2022514116A5 (https=) | ||
| JP2022539585A5 (https=) | ||
| JP2022538609A5 (https=) | ||
| JP2022540396A5 (https=) | ||
| Pol et al. | Trial Watch: DNA vaccines for cancer therapy | |
| CN111818940A (zh) | 用作疫苗的内源性肿瘤衍生的环状rna及其蛋白质 | |
| JP2022539157A5 (https=) | ||
| CN114929264A (zh) | 多结构域蛋白疫苗 | |
| CN106243213B (zh) | 一种肿瘤相关抗原XAGE-1b短肽及应用 | |
| KR20230069956A (ko) | 이종 프라임 부스트 백신 | |
| JP2024105526A (ja) | 免疫応答を誘導するための組成物 | |
| CN109970846A (zh) | 一种肿瘤相关抗原XAGE-1b九肽及其应用 | |
| US10736955B2 (en) | Fusion protein comprising bacteriophage λ GpD fused to a GP2 antigen derived from HER-2/neu | |
| JP2014139185A5 (https=) | ||
| JP2011506497A5 (https=) | ||
| JP2022501046A (ja) | アルギナーゼ１ポリペプチド | |
| Bronte | Genetic vaccination for the active immunotherapy of cancer | |
| CN104837497A (zh) | 用于预防和治疗HPV-相关的肿瘤和其它表达p16的肿瘤的p16INK4a衍生肽 | |
| Deng et al. | A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line | |
| Parvanova et al. | The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination |